ProPhase Labs, Inc.
PRPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000868278
No open-market purchases or sales by ProPhase Labs, Inc. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $2 in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding ProPhase Labs, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 35 | 27 | −8 |
| Shares | 1.96M | 1.69M | −271.8K (−13.9%) |
| Value | $8.56M | $7.63M | −$932.9K (−10.9%) |
New holders (1)
Institutions that held ProPhase Labs, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Advisory Services Network, LLC | 600 | $2.71K | 0.00% |
Sold out (9)
Institutions that held ProPhase Labs, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| American Century Companies Inc | 76,531 | $334.4K |
| Koss-Olinger Consulting, LLC | 42,081 | $184.0K |
| O'Shaughnessy Asset Management, LLC | 19,822 | $86.6K |
| Victory Capital Management Inc | 17,897 | $78.2K |
| Winton Group Ltd | 16,331 | $71.4K |
| Dimensional Fund Advisors LP | 11,039 | $48.2K |
| Citadel Advisors LLC | 3,272 | $14.3K |
| Steward Partners Investment Advisory, LLC | 2,900 | $12.7K |
| Sunbelt Securities, Inc. | 294 | $1.28K |